Chatbot coach aims to ease tough family talks about nursing home care
NCT ID NCT07448649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called ChatACP that sends daily messages and uses a chatbot to help family members of nursing home residents prepare for advance care planning—discussions about future medical and personal care. About 60 family members will use the program for 10 days and then share their experiences through surveys and interviews. The goal is to see if this approach makes families feel more ready and able to have these important conversations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * aged 18 years or older * providing care for an older adult (age 65 or above) living in a care home as a family member (including the family members in the traditional sense and the guardian and persons close to or significant to the older adult) * able to read, write and communicate in Cantonese or Mandarin * the resident, care recipient, having a prefrail or frail status as defined by a score of 3 or above on the Clinical Frailty Scale (CFS) * having a mobile device to receive instant messages and access to cellular network * engaged in minimal or no prior EOL care discussions with the care home resident as defined by a self-reported status of pre contemplation/contemplation stage on ACP discussions with the resident using the ACP staging algorithm Exclusion Criteria: * suffering from moderate to severe cognitive impairment defined by an Abbreviated Mental Test score of 5 or less and unable to give consent * suffering from communication problems (e.g., deafness or aphasia)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advance care planning are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a video chat keep dementia care true to Patients' wishes?
- A new care model asks: what matters most to people with diabetic foot ulcers?
- Culturally tailored questionnaire aims to boost advance care planning in indigenous communities
- ER visit sparks life planning: study tests motivational interviewing for advance care planning
- Card game aims to ease End-of-Life planning, but study never started
- New web app aims to give heart patients a voice in End-of-Life care